Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Daiichi Sankyo
Queensland Health
McKesson
Baxter
QuintilesIMS
Express Scripts
Fuji

Generated: October 20, 2018

DrugPatentWatch Database Preview

PRELAY Drug Profile

« Back to Dashboard

When do Prelay patents expire, and what generic alternatives are available?

Prelay is a drug marketed by Sankyo and is included in one NDA.

The generic ingredient in PRELAY is troglitazone. Additional details are available on the troglitazone profile page.

Drug patent expirations by year for PRELAY
Synonyms for PRELAY
(+-)-all-rac-5-(p-((6-Hydroxy-2,5,7,8-tetramethyl-2-chromanyl)methoxy)benzyl)-2,4-thiazolidinedione
(+/-)-5-[4-[(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]benzyl]-2,4-thiazolidinedione
(5R)-5-[[4-[[(2S)-6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl]methoxy]phenyl]methyl]thiazolidine-2,4-dione
18524-EP2269989A1
18524-EP2270011A1
18524-EP2272825A2
18524-EP2272841A1
18524-EP2275414A1
18524-EP2295409A1
18524-EP2298742A1
18524-EP2301936A1
18524-EP2305219A1
18524-EP2305648A1
18524-EP2308847A1
18524-EP2314576A1
18524-EP2314588A1
2,4-Thiazolidinedione, 5-((4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy)phenyl)methyl)-
2,4-thiazolidinedione, 5-[[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-
2,4-Thiazolidinedione, 5-[[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]- (9CI)
2,4-Thiazolidinedione, 5-[[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-(9CI)
2,4-thiazolidinedione,5-((4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2h-1-b
2,4-Thiazolidinedione,5-[[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-
322T877
5-?[[4-?[(3,?4-?DIHYDRO-?6-?HYDROXY-?2,?5,?7,?8-?TETRAMETHYL-?2H-?1-?BENZOPYRAN-?2-?YL)METHOXY]PHENYL]METHYL]-?2,?4-?THIAZLIDINEDIONE
5-(4-((6-hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione)
5-(4-((6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy)benzyl)thiazolidine-2,4-dione
5-(4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)thiazolidine-2
5-(4-(6-Hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)thiazolidine-2,4-dione
5-[(4-{[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methyl]oxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione
5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1- benzopyran-2-yl)methoxy]phenyl]methyl]-2,4-thiazlidinedione
5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-2,4-thiazolidinedione
5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl)methoxy]phenyl]methyl]thiazolidine-2,4-dione
5-[[4-[(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
5-[4-(6-Hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-ylmethoxy)benzyl]thiazolidine-2,4-dione
5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-2,4-dioxothiazolidine
5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]thiazolidine -2,4-dione
5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]thiazolidine-2,4-dione
5-{4-(6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-yl-methoxy) benzyl) thiazolidine-2,4-dione
5-{4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2h-chromen-2-yl)methoxy]benzyl}-1,3-thiazolidin-2,4-dion
5-{4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione
97322-87-7
AB00643330-02
AB0125513
AC1L1KOT
AK307955
AKOS000281116
AKOS024457434
Ambap97322-87-7
AN-34774
API0004529
BC686826
BDBM50088494
BDBM50101974
BG0468
BRD-A13084692-001-02-5
BRN 4338399
C-22371
C24H27NO5S
CAS-97322-87-7
CC-35518
CCG-208125
CCRIS 8969
CHEBI:9753
CHEMBL3542292
CI 991
CI-991
ci991
CS 045
CS-045
CS-1634
CS045
CTK7H5564
D00395
D06XZW
DB00197
DR002731
DSSTox_CID_3719
DSSTox_GSID_23719
DSSTox_RID_77162
DTXSID8023719
enzopyran-2-yl)methoxy)phenyl)methyl)-
FT-0630994
GP8940
GR 92132X
GR-92132X
GR92132X
GTPL2693
GXPHKUHSUJUWKP-UHFFFAOYSA-N
HE126916
HMS2089D22
HMS2093D04
HMS3649G12
HSCI1_000037
HY-50935
I14-1977
K752
KB-81354
KS-00001DVG
LS-151313
MLS006010817
MolPort-003-666-725
NCGC00161599-01
NCGC00161599-02
NCGC00161599-03
NCGC00161599-04
NCGC00161599-05
NCGC00161599-06
NCGC00161599-07
NCGC00161599-08
NCGC00161599-09
NCGC00161599-11
NCGC00164445-01
NCGC00254440-01
Noscal
Parke Davis brand of troglitazone
Resulin
Resulin (TN)
resulin(tm)
Rezulin
Rezulin (TN)
Romglizone
Romozin
Romozin (TN)
s8432
SC-46000
SCHEMBL4959
SMP2_000224
SMR001550129
Spectrum5_001973
SR-05000000454
SR-05000000454-3
SR-05000000454-5
Tox21_112119
Tox21_112119_1
Tox21_300470
troglitazona
troglitazone
Troglitazone (CS-045)
Troglitazone (JAN/USAN/INN)
Troglitazone [USAN:BAN:INN]
Troglitazone, >=98% (HPLC)
troglitazonum
UPCMLD-DP017
UPCMLD-DP017:001
UPCMLD-DP017:002
VA11909
Warner-Lambert brand of troglitazone

US Patents and Regulatory Information for PRELAY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sankyo PRELAY troglitazone TABLET;ORAL 020719-001 Jan 29, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-003 Aug 4, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-002 Jan 29, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for PRELAY

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sankyo PRELAY troglitazone TABLET;ORAL 020719-001 Jan 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-002 Jan 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-003 Aug 4, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-003 Aug 4, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-002 Jan 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-001 Jan 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-001 Jan 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Daiichi Sankyo
Queensland Health
McKesson
Baxter
QuintilesIMS
Express Scripts
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.